Clinical Trial Update: Testosterone Replacement Therapy and Liraglutide Effects on Weight Loss in Hypogonadism. [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating testosterone replacement therapy and liraglutide effects on weight loss in men with hypogonadism and obesity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism
• Obesity

Drugs mentioned

• Testosterone replacement therapy (testosterone)
• liraglutide (liraglutide)

Snippet

Sponsor: University Medical Centre Ljubljana | Conditions: Hypogonadism, Obesity | Phase 4 | Status: COMPLETED